Tenon Medical, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Tenon Medical, Inc. (TNON) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $412.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-13
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $412.00K, a 1.20% decline year-over-year.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $331.00K, a 62.04% decline year-over-year.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-12-31 was $344.00K, a 61.04% decline year-over-year.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $58.00K, a 93.63% decline year-over-year.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $1.69M, a 56.02% decline from fiscal 2024.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $3.85M, a 7.24% decline from fiscal 2023.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $4.14M, a 43.08% increase from fiscal 2022.
- Tenon Medical, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $2.90M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 4 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $412.00K 10-Q · filed 2026-08-13 | $743.00K 10-Q · filed 2026-08-13 | $1.09M derived: sum of 3 quarters · filed 2026-08-13 | $1.15M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $331.00K 10-Q · filed 2026-05-15 | $675.00K derived: sum of 2 quarters · filed 2026-05-15 | $733.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.15M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $402.00K derived: sum of 2 quarters · filed 2026-03-27 | $819.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.69M 10-K · filed 2026-03-27 | |
| 2025-09-30 | $58.00K 10-Q · filed 2025-11-13 | $475.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.35M 10-Q · filed 2025-11-13 | $2.23M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $417.00K 10-Q · filed 2026-08-13 | $1.29M 10-Q · filed 2026-08-13 | $2.17M derived: sum of 3 quarters · filed 2026-08-13 | $3.08M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $872.00K 10-Q · filed 2026-05-15 | $1.75M derived: sum of 2 quarters · filed 2026-05-15 | $2.67M derived: sum of 3 quarters · filed 2026-05-15 | $3.70M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $883.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.79M derived: sum of 2 quarters · filed 2026-03-27 | $2.83M derived: sum of 3 quarters · filed 2026-03-27 | $3.85M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $910.00K 10-Q · filed 2025-11-13 | $910.00K 10-Q · filed 2024-11-14 | $1.94M derived: sum of 2 quarters · filed 2025-11-13 | $2.96M 10-Q · filed 2025-11-13 | $3.94M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.03M 10-Q · filed 2025-08-13 | $2.05M 10-Q · filed 2025-08-13 | $3.03M derived: sum of 3 quarters · filed 2025-08-13 | $4.10M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $1.02M 10-Q · filed 2025-05-13 | $2.00M derived: sum of 2 quarters · filed 2025-05-13 | $3.07M derived: sum of 3 quarters · filed 2025-05-13 | $4.12M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $2.05M derived: sum of 2 quarters · filed 2025-03-26 | $3.10M derived: sum of 3 quarters · filed 2025-03-26 | $4.14M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.07M 10-Q · filed 2024-11-14 | $2.12M derived: sum of 2 quarters · filed 2024-11-14 | $3.16M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $1.05M 10-Q · filed 2024-08-13 | $2.09M 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | $1.04M 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | $2.90M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |